Asthma Clinical Trials in Phoenix

Showing 281-294 of 294 trials

Study Evaluating the Safety and Effects of MN-221 in Subjects Experiencing an Acute Exacerbation of Asthma

NCT00683449

The objective of this clinical study is to examine the safety and effectiveness of intravenous MN-221 compared to placebo when administered as an adjunct to standard therapy in subjects experiencing an acute exacerbation of asthma.

AsthmaStatus Asthmaticus

MediciNova29 participantsStarted Jun 2008

Phoenix, Arizona, United States • Los Angeles, California, United States • Sylmar, California, United States +6 more locations

UNKNOWNPhase 4< 1 mile

A Pilot Study Involving an Asthma Management Program for Inner-city Early Head Start Children

NCT00624429

The Early Head Start program serves lower socioeconomic inner-city children from birth to 3 years. This population has a higher incidence of asthma due to increased exposures. The primary objective of this study is: To evaluate the effect of early identification of these high risk, inner-city asthmatic infants, age 1-3 years, and early treatment with pulmicort respules on asthma morbidity (asthma symptoms and use of rescue medications), infant pulmonary functions, and use of health care resources (unscheduled clinic visits, emergency room visits and hospitalizations). To obtain pilot behavior information using Carey Temperament Scale, Bitsea and expand to Itsea if indicated.

Asthma

Phoenix Children's Hospital20 participantsStarted Mar 2008

Phoenix, Arizona, United States

Study Evaluating the Safety and Effects of MN-221 in Subjects Experiencing an Acute Exacerbation of Asthma

A Pilot Study Involving an Asthma Management Program for Inner-city Early Head Start Children

Asthma Trials in Other Cities

Efficacy and Safety of Different Doses of Indacaterol

Evaluate the Effect of Omalizumab on Markers of Asthma Impairment in Patients With Persistent Allergic Asthma

Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo, in Patients With Asthma

Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma

Efficacy, Safety and Pharmacokinetics of Different Regimens of Indacaterol

A Two-week Study Assessing the Onset of Effect Questionnaire (OEQ) Administered Daily Versus Weekly in Adult Subjects

Reliability of a Top Mount Actuation Indicator With Levalbuterol MDI in Adult and Pediatric Subjects With Asthma or COPD

A Safety and Tolerability Study of Levalbuterol HFA Metered Dose Inhaler in Subjects With Asthma

Safety and Tolerability Study of Levalbuterol HFA Compared to Racemic Albuterol HFA in Subjects With Asthma

Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant Patients

Study to Evaluate the Human Infection of the Lower Respiratory Tract in Children at High Risk

The Oscillation for ARDS Treated Early (OSCILLATE) Trial Pilot Study

Other Conditions in Phoenix